December 2009 – Fourth Quarter 2009 Statistical Review Mid-Atlantic Deal Review Editor’s Note: The December edition consists only of a statistical review of 4th Quarter Mid-Atlantic capital markets activity with associated commentary. Quick Stats from Chessiecap is the most comprehensive and thoroughly researched presentation of Mid-Atlantic transaction data available—Private Placements, M&A and Public Offerings. Mid-Atlantic […]
November 2009 Mid-Atlantic Deal Review from Chessiecap, Inc. Editor’s Note: Running late for Nov reporting, but I think you will find the Deal and News Notes sections informative. This is the 3rd Edition of the Mid-Atlantic Deal Review, a monthly review of transaction activity in the D.C.-Maryland-Virginia-West Virginia region. This edition is a Free Trial, […]
No signs of a reviving deal economy in the November data. November was an unusual month where Maryland (paced by a large M&A deal) captured 87% of M&A volume and 71% of private placement volume (half of which was Biotech). In general, in recent months, Maryland companies have been more in need of capital and […]
October 2009 Mid-Atlantic Deal Review Trial Edition from Chessiecap, Inc. Editor’s Note: Welcome to the 2nd Edition of the Mid-Atlantic Deal Review, a monthly review of transaction activity in the D.C.-Maryland-Virginia-West Virginia region. This edition is a Free Trial, which we hope will begin to add great value to your work and knowledge of the […]
October Private Placements knocked the ball out of the park ($289M) with several major investments in Telecom and Biotech. Meanwhile, both M&A and the struggling local market for Public Offerings fell off the table. Private Placements: October was dominated by several gigantic placements that blur the line between buyout and venture investment
September 2009 Mid-Atlantic Deal Review from Chessiecap, Inc. Editor’s Note: Welcome to the Inaugural Edition of the Mid-Atlantic Deal Review, a periodic review of transaction activity in the D.C.-Maryland-Virginia-West Virginia region. Measure real activity in the region. Entertain and Inform. Pull no punches. Get beneath the surface of deals, news and trends. Participate. Stat Notes: […]
Private Placements: Biotech had a busy month in September. Ten of the 25 private placements and 42% of private placement volume were Biotech related. Sleep Solutions, which raised $20M and works structurally with sleep apnea, is classified Healthcare. If you combine these two related categories, Healthcare-Biotech was the overwhelming recipient of dollars in September.